Cargando…

Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial

BACKGROUND: To compare the effectiveness of 550 mg naproxen sodium versus 6 mL 2%-lidocaine intracervical block in pain lowering at the 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) placement in young women. METHODS: In this randomized controlled trial, 100 women aged 15–24 years were...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Elaine Cristina Fontes, Baêta, Thaís, Brant, Ana Paula Caldeira, Silva-Filho, Agnaldo, Rocha, Ana Luiza Lunardi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556879/ https://www.ncbi.nlm.nih.gov/pubmed/34715839 http://dx.doi.org/10.1186/s12905-021-01521-z

Ejemplares similares

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
por: de Oliveira, Elaine Cristina Fontes, et al.
Publicado: (2023)

Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device
por: Creinin, Mitchell D., et al.
Publicado: (2023)

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
por: Teal, Stephanie B., et al.
Publicado: (2019)

Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
por: Wittmann, Barbara Zantut, et al.
Publicado: (2020)

Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use
por: Miranda, Laura, et al.
Publicado: (2021)

Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?
por: van der Heijden, Patty A.H.H., et al.
Publicado: (2022)

Intracervical insemination versus intrauterine insemination with cryopreserved donor sperm in the natural cycle: a randomized controlled trial
por: Kop, P A L, et al.
Publicado: (2022)

Intrauterine lidocaine and naproxen for analgesia during intrauterine device insertion: randomized controlled trial
por: Miles, Shana M., et al.
Publicado: (2019)

The AID study: protocol for a randomised controlled trial of intrauterine insemination in the natural cycle compared with intracervical insemination in the natural cycle
por: Kop, Petronella, et al.
Publicado: (2019)

Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
por: Rowe, Patrick, et al.
Publicado: (2016)

Chronic Urticaria Suspected to be Caused by a 13.5 mg Levonorgestrel Intrauterine Device (Skyla®)
por: Ganguli, Malika P, et al.
Publicado: (2023)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
por: Beatty, Megan N, et al.
Publicado: (2009)

Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system
por: Shawki, Osama, et al.
Publicado: (2013)

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
por: Kim, Mi-La, et al.
Publicado: (2013)

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
por: Jacobstein, Roy, et al.
Publicado: (2015)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017)

Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
por: Lang, Benjamin, et al.
Publicado: (2018)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
por: Kailasam, Chandra, et al.
Publicado: (2008)

Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013)

The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa
por: Hubacher, David
Publicado: (2015)

Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis
por: Sergison, Jill E., et al.
Publicado: (2019)

The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008–2012
por: Bingham, Amie L., et al.
Publicado: (2018)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
por: Choi, Sangwon, et al.
Publicado: (2021)

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: Yang, Siyuan, et al.
Publicado: (2022)

Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia
por: Gök, Soner, et al.
Publicado: (2022)

Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
por: Roman, Jose D
Publicado: (2022)

Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience
por: Wildemeersch, Dirk, et al.
Publicado: (2017)

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners
por: Nanda, Geeta, et al.
Publicado: (2018)

Effects of the levonorgestrel‐releasing intrauterine device on the immune microenvironment of the human cervix and endometrium
por: Shanmugasundaram, Uma, et al.
Publicado: (2016)

Provision of the levonorgestrel intrauterine system in Nigeria: Provider perspectives and service delivery costs
por: Brunie, Aurélie, et al.
Publicado: (2020)

The lost intrauterine levonorgestrel-releasing system in women with adenomyosis: A case report
por: Gunardi, Eka Rusdianto, et al.
Publicado: (2022)

Retracted: Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial
por: Todd, Catherine S., et al.
Publicado: (2020)

Comparative study of the levonorgestrel intrauterine system and laparoscopic hysterectomy for the treatment of heavy menstrual bleeding in enlarged uteri
por: Depes, Daniella De Batista, et al.
Publicado: (2023)

Corrigendum to “Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A” [Contraception 2016;93:498–506]
por: Rowe, Patrick, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kal0turouu0dth1tc7gkbqjitl